Symptom burden and quality of life in patients with high-risk essential thrombocythaemia and polycythaemia vera receiving hydroxyurea or pegylated interferon alfa-2a: a post-hoc analysis of the MPN-RC 111 and 112 trials

2022 ◽  
Vol 9 (1) ◽  
pp. e38-e48 ◽  
Author(s):  
Gina L Mazza ◽  
Carolyn Mead-Harvey ◽  
John Mascarenhas ◽  
Abdulraheem Yacoub ◽  
Heidi E Kosiorek ◽  
...  
2008 ◽  
Vol 23 ◽  
pp. S383
Author(s):  
A. Kordon ◽  
U. Ancker ◽  
D. Schlueter ◽  
L. Hargarter ◽  
F. Mattejat ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document